Sigachi Industries informs about press release

Sigachi Industries has informed that Sigachi Industries, a leading Indian pharmaceutical company, today announced a significant milestone in its research and development pipeline with the successful advancement of a new Cystic Fibrosis (CF) Active Pharmaceutical Ingredients (APIs) combination comprising Vanzacaftor, Tezacaftor, and Deutivacaftor. A press release to this extent is enclosed.

The above information is a part of company’s filings submitted to BSE.